NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

敗血症治療的全球市場:產業分析,規模,佔有率,成長,趨勢,及預測(2021年∼2031年)

Sepsis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

出版商 Transparency Market Research 商品編碼 1008635
出版日期 內容資訊 英文 188 Pages
商品交期: 最快1-2個工作天內
價格
敗血症治療的全球市場:產業分析,規模,佔有率,成長,趨勢,及預測(2021年∼2031年) Sepsis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031
出版日期: 2021年04月08日內容資訊: 英文 188 Pages
簡介

本報告提供全球敗血症治療市場的相關調查,市場規模和預測,趨勢和機會,成長及阻礙因素,各類型、療法、終端用戶、地區的市場分析,競爭情形,COVID-19的影響,主要企業的簡介等資訊。

目錄

第1章 序文

第2章 前提條件與調查手法

第3章 摘要整理:全球敗血症治療市場

第4章 市場概要

  • 簡介
    • 市場定義
    • 產業的演進/發展
  • 概要
  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 全球敗血症治療市場分析與預測(2017-2031)
    • 市場收益預測

第5章 重要的洞察

  • 敗血症人口
  • 敗血症的總住院數(一般病房以及其他,ICU的住院數)
  • 主要的產業活動(合併,收購,聯盟,合作等)
  • COVID-19大流行的對產業的影響(價值鏈及短期/中期/長期影響)

第6章 各類型:全球敗血症治療市場分析與預測

  • 簡介和定義
  • 主要調查結果/開發
  • 全球敗血症治療市場銷售額預測(2017-2031)
    • 重病敗血症
    • 敗血性休克
    • 血液淨化需要的敗血症
  • 各類型市場魅力分析

第7章 各療法:全球敗血症治療市場分析與預測

  • 簡介和定義
  • 主要調查結果/開發
  • 全球敗血症治療市場銷售額預測(2017-2031)
    • 連續性腎替代性治療(CRRT)
    • 間歇的血液透析機
    • 持續低效率連日血液透析機(SLEDD)
    • 其他
  • 各療法市場魅力分析

第8章 各終端用戶:全球敗血症治療市場分析與預測

  • 簡介和定義
  • 主要調查結果/開發
  • 全球敗血症治療市場銷售額預測(2017-2031)
    • 醫院
    • 專門中心
    • 其他
  • 各終端用戶市場魅力分析

第9章 各地區:全球敗血症治療市場分析與預測

  • 主要調查結果
  • 全球敗血症治療市場銷售額預測
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東、非洲
  • 各地區市場的魅力分析

第10章 北美的敗血症治療市場分析與預測

  • 簡介
    • 主要調查結果
  • 北美的敗血症治療市場銷售額預測:各類型(2017-2031)
  • 北美的敗血症治療市場銷售額預測:各療法(2017-2031)
  • 北美的敗血症治療市場銷售額預測:各終端用戶(2017-2031)
  • 北美的敗血症治療市場銷售額預測:各國(2017-2031)
    • 美國
    • 加拿大
  • 北美敗血症治療市場魅力分析
    • 各類型
    • 各療法
    • 各終端用戶
    • 各國

第11章 歐洲的敗血症治療市場分析與預測

第12章 亞太地區的敗血症治療市場分析與預測

第13章 南美的敗血症治療市場分析與預測

第14章 中東及非洲的敗血症治療市場分析與預測

第15章 競爭情形

  • 市場企業-競爭矩陣(企業的階層與各規模)
  • 企業簡介
    • Baxter International, Inc.
    • Fresenius Medical Care AG &Co. KGaA
    • Nipro Corporation
    • Asahi Kasei
    • B. Braun Group
    • CytoSorbents Corporation
    • Medtronic plc
    • Nikkiso Co., Ltd.
    • Medica SPA
    • Toray Industries
    • Merck &Co., Inc.
目錄
Product Code: TMRGL81989

Scope of the Report

TMR's report on the global sepsis treatment market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2021 to 2031. The report provides the overall revenue of the global sepsis treatment market for the period 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global sepsis treatment market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global sepsis treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of the top-down and bottom-up approaches to study various phenomena in the global sepsis treatment market.

The report comprises an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global sepsis treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global sepsis treatment market. The next section of the global sepsis treatment market report highlights the USPs, which include technological advancements, key industry events (mergers, acquisitions, strategic partnerships, etc.), top three players operating in the market space, and COVID-19 pandemic impact on the global sepsis treatment market.

The report delves into the competitive landscape of the global sepsis treatment market. Key players operating in the global sepsis treatment market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global sepsis treatment market report.

Key Questions Answered:

  • What are the sales/revenue generated by sepsis manufacturers across all regions during the forecast period?
  • What are the key trends in the global sepsis market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which segment will have the highest revenue globally in 2031 and which segment will expand at the highest CAGR during the forecast period?
  • What was the market ranking of different companies operating in the global market in 2020?

Research Objectives and Research Approach

The comprehensive report on the global sepsis treatment market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global sepsis treatment market. It is followed by market introduction, market dynamics, and an overview of the global sepsis treatment market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the global sepsis treatment market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key product manufacturers has been mapped to ascertain the size of the global sepsis treatment market in terms of value. The forecast presented here assesses the total revenue generated in the global sepsis treatment market. In order to provide an accurate forecast, we initiated by sizing of the current sepsis treatment market with the help of the parent market.

The report analyzes the global sepsis treatment market in terms of type, therapy, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2031 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global sepsis treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Sepsis Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Market Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Sepsis Treatment Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Sepsis Population (admissions as % of population)
  • 5.2. Total Sepsis Hospital Admissions [general ward & other, ICU patients admitted (000)]
  • 5.3. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
  • 5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Sepsis Treatment Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Global Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017-2031
    • 6.3.1. Severe Sepsis
    • 6.3.2. Septic Shock
    • 6.3.3. Sepsis in Need of Blood Purification
  • 6.4. Global Sepsis Treatment Market Attractiveness Analysis, by Type

7. Global Sepsis Treatment Market Analysis and Forecast, by Therapy

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Global Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017-2031
    • 7.3.1. Continuous Renal Replacement Therapies (CRRT)
    • 7.3.2. Intermittent Hemodialysis
    • 7.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)
    • 7.3.4. Others
  • 7.4. Global Sepsis Treatment Market Attractiveness Analysis, by Therapy

8. Global Sepsis Treatment Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Global Sepsis Treatment Market Value (US$ Bn) Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. Specialty Centers
    • 8.3.3. Others
  • 8.4. Global Sepsis Treatment Market Attractiveness Analysis, by End-user

9. Global Sepsis Treatment Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Global Sepsis Treatment Market Value (US$ Bn) Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Global Sepsis Treatment Market Attractiveness Analysis, by Region

10. North America Sepsis Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. North America Sepsis Treatment Market Value (US$ Bn) Forecast, by Type , 2017-2031
    • 10.2.1. Severe Sepsis
    • 10.2.2. Septic Shock
    • 10.2.3. Sepsis in Need of Blood Purification
  • 10.3. North America Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017-2031
    • 10.3.1. Continuous Renal Replacement Therapies (CRRT)
    • 10.3.2. Intermittent Hemodialysis
    • 10.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)
    • 10.3.4. Others
  • 10.4. North America Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017-2031
    • 10.4.1. Hospitals
    • 10.4.2. Specialty Centers
    • 10.4.3. Others
  • 10.5. North America Sepsis Treatment Market Value (US$ Bn) Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. North America Sepsis Treatment Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By Therapy
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Sepsis Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Europe Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017-2031
    • 11.2.1. Severe Sepsis
    • 11.2.2. Septic Shock
    • 11.2.3. Sepsis in Need of Blood Purification
  • 11.3. Europe Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017-2031
    • 11.3.1. Continuous Renal Replacement Therapies (CRRT)
    • 11.3.2. Intermittent Hemodialysis
    • 11.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)
    • 11.3.4. Others
  • 11.4. Europe Sepsis Treatment Market Value (US$ Bn) Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
    • 11.4.2. Specialty Centers
    • 11.4.3. Others
  • 11.5. Europe Sepsis Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Europe Sepsis Treatment Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By Therapy
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Sepsis Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Asia Pacific Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017-2031
    • 12.2.1. Severe Sepsis
    • 12.2.2. Septic Shock
    • 12.2.3. Sepsis in Need of Blood Purification
  • 12.3. Asia Pacific Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017-2031
    • 12.3.1. Continuous Renal Replacement Therapies (CRRT)
    • 12.3.2. Intermittent Hemodialysis
    • 12.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)
    • 12.3.4. Others
  • 12.4. Asia Pacific Sepsis Treatment Market Value (US$ Bn) Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
    • 12.4.2. Specialty Centers
    • 12.4.3. Others
  • 12.5. Asia Pacific Sepsis Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Asia Pacific Sepsis Treatment Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By Therapy
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Sepsis Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Latin America Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017-2031
    • 13.2.1. Severe Sepsis
    • 13.2.2. Septic Shock
    • 13.2.3. Sepsis in Need of Blood Purification
  • 13.3. Latin America Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017-2031
    • 13.3.1. Continuous Renal Replacement Therapies (CRRT)
    • 13.3.2. Intermittent Hemodialysis
    • 13.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)
    • 13.3.4. Others
  • 13.4. Latin America Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017-2031
    • 13.4.1. Hospitals
    • 13.4.2. Specialty Centers
    • 13.4.3. Others
  • 13.5. Latin America Sepsis Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Latin America Sepsis Treatment Market Attractiveness Analysis
    • 13.6.1. By Type
    • 13.6.2. By Therapy
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Sepsis Treatment Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Middle East & Africa Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017-2031
    • 14.2.1. Severe Sepsis
    • 14.2.2. Septic Shock
    • 14.2.3. Sepsis in Need of Blood Purification
  • 14.3. Middle East & Africa Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017-2031
    • 14.3.1. Continuous Renal Replacement Therapies (CRRT)
    • 14.3.2. Intermittent Hemodialysis
    • 14.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)
    • 14.3.4. Others
  • 14.4. Middle East & Africa Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017-2031
    • 14.4.1. Hospitals
    • 14.4.2. Specialty Centers
    • 14.4.3. Others
  • 14.5. Middle East & Africa Sepsis Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Middle East & Africa Sepsis Treatment Market Attractiveness Analysis
    • 14.6.1. By Type
    • 14.6.2. By Therapy
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competitive Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Company Profiles
    • 15.2.1. Baxter International, Inc.
      • 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.1.2. Financial Overview
      • 15.2.1.3. Product Portfolio
      • 15.2.1.4. Strategic Overview
      • 15.2.1.5. SWOT Analysis
    • 15.2.2. Fresenius Medical Care AG & Co. KGaA
      • 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.2.2. Financial Overview
      • 15.2.2.3. Product Portfolio
      • 15.2.2.4. Strategic Overview
      • 15.2.2.5. SWOT Analysis
    • 15.2.3. Nipro Corporation
      • 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.3.2. Financial Overview
      • 15.2.3.3. Product Portfolio
      • 15.2.3.4. Strategic Overview
      • 15.2.3.5. SWOT Analysis
    • 15.2.4. Asahi Kasei
      • 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.4.2. Financial Overview
      • 15.2.4.3. Product Portfolio
      • 15.2.4.4. Strategic Overview
      • 15.2.4.5. SWOT Analysis
    • 15.2.5. B. Braun Group
      • 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.5.2. Product Portfolio
      • 15.2.5.3. Strategic Overview
      • 15.2.5.4. SWOT Analysis
    • 15.2.6. CytoSorbents Corporation
      • 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.6.2. Financial Overview
      • 15.2.6.3. Product Portfolio
      • 15.2.6.4. Strategic Overview
      • 15.2.6.5. SWOT Analysis
    • 15.2.7. Medtronic plc
      • 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.7.2. Financial Overview
      • 15.2.7.3. Product Portfolio
      • 15.2.7.4. Strategic Overview
      • 15.2.7.5. SWOT Analysis
    • 15.2.8. Nikkiso Co., Ltd.
      • 15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.8.2. Financial Overview
      • 15.2.8.3. Product Portfolio
      • 15.2.8.4. Strategic Overview
      • 15.2.8.5. SWOT Analysis
    • 15.2.9. Medica SPA
      • 15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.9.2. Financial Overview
      • 15.2.9.3. Product Portfolio
      • 15.2.9.4. Strategic Overview
      • 15.2.9.5. SWOT Analysis
    • 15.2.10. Toray Industries
      • 15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.10.2. Financial Overview
      • 15.2.10.3. Product Portfolio
      • 15.2.10.4. Strategic Overview
      • 15.2.10.5. SWOT Analysis
    • 15.2.11. Merck & Co., Inc.
      • 15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.11.2. Financial Overview
      • 15.2.11.3. Product Portfolio
      • 15.2.11.4. Strategic Overview
      • 15.2.11.5. SWOT Analysis

List of Tables

  • Table 01: Global Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 02: Global Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017-2031
  • Table 03: Global Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Sepsis Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Sepsis Treatment Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 07: North America Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017-2031
  • Table 08: North America Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Sepsis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 11: Europe Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017-2031
  • Table 12: Europe Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific Sepsis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 15: Asia Pacific Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017-2031
  • Table 16: Asia Pacific Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America Sepsis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 19: Latin America Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017-2031
  • Table 20: Latin America Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa Sepsis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 23: Middle East & Africa Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017-2031
  • Table 24: Middle East & Africa Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Sepsis Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Sepsis Treatment Market Value Share, by Type, 2020
  • Figure 03: Global Sepsis Treatment Market Value Share, by Therapy, 2020
  • Figure 04: Global Sepsis Treatment Market Value Share, by End-user, 2020
  • Figure 05: Global Sepsis Treatment Market Value Share, by Region, 2020
  • Figure 06: Global Sepsis Treatment Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 07: Global Sepsis Treatment Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 08: Global Sepsis Treatment Market Revenue (US$ Mn), by Severe Sepsis/Sepsis, 2017-2031
  • Figure 09: Global Sepsis Treatment Market Revenue (US$ Mn), by Septic Shock, 2017-2031
  • Figure 10: Global Sepsis Treatment Market Revenue (US$ Mn), by Sepsis in Need of Blood Purification, 2017-2031
  • Figure 11: Global Sepsis Treatment Market Value Share Analysis, by Therapy, 2020 and 2031
  • Figure 12: Global Sepsis Treatment Market Attractiveness Analysis, by Therapy, 2021-2031
  • Figure 13: Global Sepsis Treatment Market Revenue (US$ Mn), by Continuous Renal Replacement Therapies (CRRT), 2017-2031
  • Figure 14: Global Sepsis Treatment Market Revenue (US$ Mn), by Intermittent Hemodialysis, 2017-2031
  • Figure 15: Global Sepsis Treatment Market Revenue (US$ Mn), by Sustained Low-efficiency Daily Dialysis (SLEDD), 2017-2031
  • Figure 16: Global Sepsis Treatment Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 17: Global Sepsis Treatment Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 18: Global Sepsis Treatment Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 19: Global Sepsis Treatment Market Revenue (US$ Mn), by Hospitals, 2017-2031
  • Figure 20: Global Sepsis Treatment Market Revenue (US$ Mn), by Specialty Centers, 2017-2031
  • Figure 21: Global Sepsis Treatment Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 22: Global Sepsis Treatment Market Value Share Analysis, by Region, 2020 and 2031
  • Figure 23: Global Sepsis Treatment Market Attractiveness Analysis, by Region, 2021-2031
  • Figure 24: North America Sepsis Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 25: North America Sepsis Treatment Market Value Share Analysis, by Country, 2020 and 2031
  • Figure 26: North America Sepsis Treatment Market Attractiveness Analysis, by Country, 2021-2031
  • Figure 27: North America Sepsis Treatment Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 28: North America Sepsis Treatment Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 29: North America Sepsis Treatment Market Value Share Analysis, by Therapy, 2020 and 2031
  • Figure 30: North America Sepsis Treatment Market Attractiveness Analysis, by Therapy, 2021-2031
  • Figure 31: North America Sepsis Treatment Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 32: North America Sepsis Treatment Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 33: Europe Sepsis Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 34: Europe Sepsis Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 35: Europe Sepsis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 36: Europe Sepsis Treatment Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 37: Europe Sepsis Treatment Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 38: Europe Sepsis Treatment Market Value Share Analysis, by Therapy, 2020 and 2031
  • Figure 39: Europe Sepsis Treatment Market Attractiveness Analysis, by Therapy, 2021-2031
  • Figure 40: Europe Sepsis Treatment Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 41: Europe Sepsis Treatment Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 42: Asia Pacific Sepsis Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 43: Asia Pacific Sepsis Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 44: Asia Pacific Sepsis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 45: Asia Pacific Sepsis Treatment Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 46: Asia Pacific Sepsis Treatment Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 47: Asia Pacific Sepsis Treatment Market Value Share Analysis, by Therapy, 2020 and 2031
  • Figure 48: Asia Pacific Sepsis Treatment Market Attractiveness Analysis, by Therapy, 2021-2031
  • Figure 49: Asia Pacific Sepsis Treatment Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 50: Asia Pacific Sepsis Treatment Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 51: Latin America Sepsis Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 52: Latin America Sepsis Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 53: Latin America Sepsis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 54: Latin America Sepsis Treatment Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 55: Latin America Sepsis Treatment Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 56: Latin America Sepsis Treatment Market Value Share Analysis, by Therapy, 2020 and 2031
  • Figure 57: Latin America Sepsis Treatment Market Attractiveness Analysis, by Therapy, 2021-2031
  • Figure 58: Latin America Sepsis Treatment Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 59: Latin America Sepsis Treatment Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 60: Middle East & Africa Sepsis Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 61: Middle East & Africa Sepsis Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 62: Middle East & Africa Sepsis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 63: Middle East & Africa Sepsis Treatment Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 64: Middle East & Africa Sepsis Treatment Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 65: Middle East & Africa Sepsis Treatment Market Value Share Analysis, by Therapy, 2020 and 2031
  • Figure 66: Middle East & Africa Sepsis Treatment Market Attractiveness Analysis, by Therapy, 2021-2031
  • Figure 67: Middle East & Africa Sepsis Treatment Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 68: Middle East & Africa Sepsis Treatment Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 69: Global Sepsis Treatment Market Share, by Company, 2019
  • Figure 70: Baxter International, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2019
  • Figure 71: Fresenius Medical Care AG & Co. KGaA Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2019
  • Figure 72: Nipro Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2019
  • Figure 73: Asahi Kasei Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2019
  • Figure 74: B. Braun Group Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2019
  • Figure 75: CytoSorbents Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2019
  • Figure 76: Medtronic Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 77: NIKKISO CO., LTD Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 78: Toray Industries Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 79: Merck & Co. Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019